4.8 Editorial Material

Improving data sharing to increase the efficiency of antibiotic R&D

期刊

NATURE REVIEWS DRUG DISCOVERY
卷 20, 期 1, 页码 1-2

出版社

NATURE PORTFOLIO
DOI: 10.1038/d41573-020-00185-y

关键词

-

资金

  1. CARB-X
  2. Biomedical Advanced Research & Development Authority [6 IDSEP160030]
  3. Wellcome Trust
  4. UK Department of Health & Social Care (GAMRIF)
  5. German Federal Ministry of Education & Research (BMBF)
  6. Bill & Melinda Gates Foundation

向作者/读者索取更多资源

Greater investment is needed in antibiotic R&D, and more must be done to maximize the impact of such investments. More widespread data sharing, such as the recent joint data contribution from Merck and Kyorin to the Pew Charitable Trusts' SPARK platform, plays a key role in this process.
Greater investment is needed in antibiotic R&D, and more must be done to maximize the impact of such investments. More widespread data sharing, such as the recent joint data contribution from Merck and Kyorin to the Pew Charitable Trusts' SPARK platform, has a key role. Greater investment is needed in antibiotic R&D, and more must be done to maximize the impact of such investments. More widespread data sharing, such as the recent joint data contribution from Merck and Kyorin to the Pew Charitable Trusts' SPARK platform, has a key role.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据